Health care stocks were declining Monday afternoon, with the NYSE Health Care Index down 0.9% and the Health Care Select Sector SPDR Fund (XLV) falling 1.1%.
The iShares Biotechnology ETF (IBB) dropped 1.1%.
In corporate news, Marinus Pharmaceuticals (MRNS) shares surged 43% after the company said it signed a deal under which Immedica Pharma will buy all of its issued and outstanding stock for $0.55 a share.
Emergent BioSolutions (EBS) shares jumped nearly 13% after HC Wainwright started coverage of the stock with a buy rating and $15 price target.
Traws Pharma (TRAW) shares tumbled over 39% after the company said it entered agreements to raise up to $72.6 million via an equity offering.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。